Johnson & Johnson Innovation launches healthcare incubator in Pudong

A logo sign outside of a facility occupied by the Johnson & Johnson consumer division in Fort Washington, Pennsylvania on April 22, 2018. [Photo/IC]
SHANGHAI - Johnson & Johnson Innovation, a division of Johnson & Johnson (China) Investment Ltd., launched a 4,400-square-meter incubator for healthcare startups in Pudong New Area, Shanghai Thursday.
The incubator "JLABS," located in Shanghai's Zhangjiang High-Tech Park, can accommodate about 50 startups and opened with 31 companies from a range of sectors including therapeutics, medical devices and medical technology.
The incubator is Johnson & Johnson Innovation's first such facility in the Asia-Pacific Region and the largest of its kind in the world. It was co-built by the company and Shanghai Pharma Engine Co. Ltd.
Paul Stoffels, vice chairman of Johnson & Johnson's executive committee, said the Shanghai incubator would connect local and global entrepreneurs to help transform ideas into breakthrough health solutions.
Melinda Richter, global head of Johnson & Johnson Innovation, said the incubator would help "identify and nurture best in class science to transform how diseases are treated, cured, prevented and intercepted."
China's public holidays for 2025
Shanghai FTZ: Go all out to build China's first pilot zone for Silk Road E-commerce cooperation
Favorable policies boost 'China Travel' trend
play